Don’t miss the latest developments in business and finance.

Nectar Lifescience secures ANVISA (Brazil) cGMP

Image
Capital Market
Last Updated : May 14 2015 | 8:01 PM IST

For Cephalosporin API's manufacturing facility

Nectar Lifescience has received ANVISA cGMP (current good manufacturing practices) approval for Brazil for its Cephalosporin API's manufacturing facility in Dera Bassi, Punjab.

Powered by Capital Market - Live News

More From This Section

First Published: May 14 2015 | 6:31 PM IST

Next Story